Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of ZL-1 in treatment-naive patients with HIV infection/AIDS
ChiCTR-IIR-17012047Phase 2Not yet recruiting
- Sponsor
- Shanghai Public Health Clinical Center
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ZL-1 in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (2 arms), sponsored by Shanghai Public Health Clinical Center. Primary endpoint: Proportion of participants with HIV RNA decrease of at least 0.5 log/mL. Planned start May 2017; status: not yet recruiting.
02
Drugs
ZL-1
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ChiCTR-IIR-17012047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17012047.